Under the new structure, due to come into effect next January, Sanofi's cancer and immunology pipeline with now sit alongside subsidiary Genzyme's ... medicines and older products still in patent ...

Marc Moodley has worked at Sanofi since 2018 and is the new medical ... How do you think NICE should change its reviews of oncology products? The NHS and the government have taken a positive ...

PARIS, October 17, 2024--(BUSINESS WIRE)--Regulatory News: Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology ...